Personal information

No personal information available

Activities

Collapse all

Works (3)

Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial

JCO Global Oncology
2024-11 | Journal article
DOI: 10.1200/GO.24.00059
Contributors: Kumar Prabhash; Chetan Deshmukh; Hemant Malhotra; Atul Sharma; Minish Jain; Nilesh Dhamne; Rajnish Nagarakar; Prasantha Ganesan; Vijay K. Mahobia; Chandan K. Das et al.
Source: check_circle
Crossref

“PALLCARE Seva”—A Beacon Amid the Catastrophic COVID-19 Times: A Cross-Sectional Study from a Rural Oncology Institute in Western Maharashtra

Indian Journal of Medical and Paediatric Oncology
2022-08 | Journal article
DOI: 10.1055/s-0042-1754371
Contributors: Chaitanya R. Patil; Prasad Tanawade; Nilesh Dhamne; Yogesh Anap; Parag Watve
Source: check_circle
Crossref

Role of ado-trastuzumab emtansine (T-DM1) in HER2 positive salivary gland tumour with brain metastasis

BMJ Case Reports
2022-05 | Journal article
DOI: 10.1136/bcr-2021-248576
Contributors: Nilesh Dhamne; Venkata Pradeep Babu Koyyala; Snehal Chougule; Suraj Pawar
Source: check_circle
Crossref
How many people are using ORCID?